NCT00950417View on ClinicalTrials.gov

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

November 30, 2012

Conditions
Advanced Esophageal
Interventions
DRUG

Nimotuzumab

Trial Locations (1)

200032

Fudan University Cancer Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Biotech Pharmaceutical Co., Ltd.

OTHER